Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Similar documents
Alcohol-related harm in Europe and the WHO policy response

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

European Status report on Alcohol and Health

European status report on alcohol and health Leadership, awareness and commitment

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Q1 What age are you?

The cancer burden in the European Union and the European Region: the current situation and a way forward

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Where we stand in EFORT

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Table 7.1 Summary information for lung cancer in Ireland,

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

LEBANON. WCPT COUNTRY PROFILE December 2018

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

DENMARK. WCPT COUNTRY PROFILE December 2018

Smokefree Policies in Europe: Are we there yet?

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

GERMANY. WCPT COUNTRY PROFILE December 2018

The burden caused by alcohol

Highlighting in the WHO European Region:

Engagement in language assessment / Regions of Europe

Table 9.1 Summary information for stomach cancer in Ireland,

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Access to treatment and disease burden

European Association of Dental Public Health Prevention of Oral Cancer

Prevention of Oral Cancer Special Interest Working Group

Table 6.1 Summary information for colorectal cancer in Ireland,

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Alcohol consumption, alcohol dependence and attributable burden of disease in Europe

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Overview of drug-induced deaths in Europe - What does the data tell us?

11 Melanoma of the skin

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

The Risk of Alcohol in Europe. Bridging the Gap June 2004

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Cannabis policies & cannabis use

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Inequality in injury risks

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

The health economic landscape of cancer in Europe

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Overall survival: 1 st line therapy

Better Health for All in Latvia

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

European Collaboration on Dementia. Luxembourg, 13 December 2006

Development of Palliative Care services in different countries

Cardiovascular disease in Europe: epidemiological update 2016

Cross Border Genetic Testing for Rare Diseases

Summary. Primary care data. Week 49/2014. Season

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Underage drinking in Europe

Monthly measles and rubella monitoring report

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Rheumatoid Arthritis Disease Burden and Access to Treatment

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

HPV vaccination How to promote women s health and prevent cancer with good screening strategies, hosted by NFOG

National burden of colorectal cancer in Lithuania and the ranking of Lithuania within the 45 European nations

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

CNAPA Meeting Luxembourg September 2016

UK bowel cancer care outcomes: A comparison with Europe

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

Summary. 10 The 2007 ESPAD Report

Where do EU Contries set the limit for low risk drinking.

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Best practices in collecting and processing data in CRC screening and after it

Alcohol Prevention Day

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Budapest, Hungary, September 2017 xx July xxx. Progress reports

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Primary and secondary prevention of sudden cardiac death in emerging economies

New scientific study: no safe level of alcohol

European Community Pharmacy: a reference in Public Health

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Terms and Conditions. VISA Global Customer Assistance Services

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Project Meeting Prague

Annals of Oncology Advance Access published November 30, Cancer mortality in Europe, , and an overview of trends since 1975

Transcription:

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada 3) WHO Collaborating Centre for Mental Health and Addictions 4) Technische Universität Dresden, Clinical Psychology and Psychotherapy, Germany jtrehm@gmail.com

What will be covered? Risk factor approach vs. disease approach Basic methodology for risk factor approach The 2010 GBD study the real data (Lim et al., 2012 is unfortunately incorrect) The situation in the Nordic and Baltic countries Cost Conclusions

Diseases vs. risk factors

Addiction (substance use disorders = disease) vs. risk factors Mortality and morbidity can be attributed to disease or injury outcomes preventable risk factors However, this distinction gets blurred with substance use and substance use disorders How many of the smoking attributable lung cancers are due to tobacco use disorders? But what is written on the cause of death certificate?

Smoking and lung cancer Below the white line in the red circle: smokers without tobacco use disorder

The risk factor approach Identification of causal relations Exposure Quantification of risk relations

Basic ingredients for a risk factor approach First disease and injury categories, where substance use disorders have causal impact, must be identified Attributable fraction must be determined, which are a function of: Prevalence of exposure Risk relations What does this mean? We need to know the prevalence of alcohol use

Currently used model for alcohol CRA 2005 Societal Factors (individual) Population group Gender Drinking culture Alcohol Policy Drinking environment Health care system Alcohol consumption Volume Patterns Quality Incidence chronic conditions including AUDs Incidence acute conditions Health outcomes Age Poverty Marginalization Mortality by cause

Basic formula Continuous distribution of drinkers Continuous RR function P a RR P RR AAF( x) max( x) P RR P RR P( x) RR( x) dx a a a ex ex min( x) where Pa is the prevalence of lifetime abstainers RRa is the relative risk of lifetime abstainers (set to 1) Pex is the prevalence of former drinkers (all types of former drinkers with no drinking in last year) RRex is the relative risk of former drinkers x average volume of alcohol consumption per day P(x) is the prevalence of alcohol with consumption x RR(x) is the relative risk of drinkers with consumption x Of course, instead of no consumption at all, other counterfactuals could be modelled. ex ex max( x) min( x) P( x) RR( x) dx -1

Volume (g/day) German Male ALL AGES Example of general population distribution of volume of drinking => basis for continuous modelling Log-Normal (red) vs. Gamma (blue) vs. Weibull (green) P re v a le n c e 0.0 0 0.0 1 0.0 2 0.0 3 0.0 4 0.0 5 0.0 6 0.0 7 Histogram of consumption with estimated consumption distributions Decision was based on comparison of distributions from 30 countries! 0 20 40 60 80 100

Best overall fit: Weibull & Gamma Gamma Distribution f(x; θ, k) = 1/( θk Γ(k)) xk-1 exp{- x / θ} Mean Estimate for the Gamma Distribution = θk Variance = θ2k Empirical and theoretical Gamma estimates for mean have to be identical, and variance estimates were quite similar. Better properties for transferring results to other populations than Weibull.

Risk relations Alcohol has the most disease and injury categories which are causally impacted (more then 200 ICD three digit codes) -> mainly not 100% attributable Tobacco is second -> mainly not 100% attributable Illicit drugs mainly overdose deaths for mortality

Risk factor assessment within GBD 2010 Published in December 2012 in Lancet by Lim et al. But The numbers for alcohol are seriously off. What I show in the next slides is already corrected -> will appear in Lancet soon

Burden of disease in DALYs One DALY is one year of life lost either due to premature mortality or to disability. If somebody is 20% disabled, living 5 years with this disablement will result in one DALY (without age weighting or discounting). Total DALYs in 2010 were 2.490 billion.

2010 GBD (% of total burden of disease)

GBD Men 2010 (% of all burden)

GBD women (% of all burden)

Men vs. women in burden of disease Tobacco: men #1, women #4 Alcohol: men #3, women #12 Illegal drugs #20, women not in top #20 Huge differences between high- and low/middle income countries Alcohol consumption varies with emancipation: the more emancipated, the higher the alcoholattributable burden of disease!

Worldwide rise in body weight and glycaemia, with rare regions where it has been stable; higher burden from overweight/obesity than undernutrition The worldwide epidemiological transition Overall improvement in mortality across the world, with near stagnation in Eastern Europe and parts of sub-saharan Africa Large declines in child mortality and in the burden for its key risk factors, leading to larger share of disease burden from NCDs (with main risk factors tobacco, alcohol, nutrition, and physical activity). A great deal more to be done in sub-saharan Africa and South Asia. Shifting burden of smoking from high-income to low-andmiddle-income countries

Western Europe (larger countries) Andorra Austria Belgium Cyprus Denmark Finland France Germany Greece Greenland Iceland Ireland Israel Italy Liechtenstein Luxembourg Malta Monaco Netherlands Norway Portugal San Marino Spain Sweden Switzerland United Kingdom

Western Europe 2010

Central Europe Albania Bosnia and Herzegovina Bulgaria Croatia Czech Republic Hungary Montenegro Poland Romania Serbia Slovakia Slovenia The Former Yugoslav Republic of Macedonia

Central Europe 2010

Eastern Europe Belarus Estonia Latvia Lithuania Republic of Moldova Russian Federation Ukraine

Eastern Europe 2010

A comparison for the Baltic countries and Finland to global figures risk factor attributable and total DALYs/100 000 12 10 8 6 4 2 0

A comparison for the Baltic countries and Finland to global figures risk factor attributable DALYs/100 000 12 10 8 6 4 2 0

Percent DALYs attributable to SU risk factors 12 10 8 6 4 2 0

Globally For tobacco there are 6.30 million deaths in 2010, for alcohol 2.74 million deaths, and for drugs 0.16 million deaths In total in 2010, there were 52.77 million deaths. Thus tobacco is causing more than 10% of all deaths (11.9%), and alcohol for about 5.2% and illegal drugs for 0.3%

Conclusion Prevalence, associated burden and economic costs of substance use and substance use disorders in Europe are staggering. For most of Europe tobacco use disorders cause the most burden and costs, for eastern Europe it is alcohol. Illegal drugs and its attributable burden is far behind, but its costs depend more on political choices than on burden. In terms of countries, the Baltics are typical for Eastern European pattern and the Nordic Countries for western European patterns.